abstract |
This invention features a medical composition for treating infection by herpesvirus. The composition includes an arylnaphthalene compound of formula (I). Each of R1 and R2, independently is R or C(O)R; or R1 and R2 taken together is (CH2)m; each of R3, R4, and R5, independently, is R, OR, C(O)R, or OC(O)R; or any two of R3, R4, and R5 taken together is O(CH2)nO; Ar is aryl; each of Z1 and Z2, independently, is CH2 or C(O); and each of R6 and R7, independently, is R, OR, SR, or NRR'; or R6 and R7 taken together is O, S, or NR; in which each of R and R', independently, is H, alkyl, (CH2)o-aryl, (CH2)p-heteroaryl, cyclyl, or heterocyclyl; each of m and n, independently, is 1, 2, 3, or 4; and each of o and p, independently, is 0, 1, 2, 3, 4, 5, or 6. |